BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 8423407)

  • 21. Decreased expression of alpha 2 beta 1 integrin in scleroderma fibroblasts.
    Kozlowska E; Sollberg S; Mauch C; Eckes B; Klein CE; Krieg T
    Exp Dermatol; 1996 Feb; 5(1):57-63. PubMed ID: 8624613
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of osteonectin, decorin, and transforming growth factor-beta 1 genes in fibroblasts cultured from patients with systemic sclerosis and morphea.
    Vuorio T; Kähäri VM; Black C; Vuorio E
    J Rheumatol; 1991 Feb; 18(2):247-51. PubMed ID: 2023219
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix remodeling in systemic sclerosis.
    Leask A
    Semin Immunopathol; 2015 Sep; 37(5):559-63. PubMed ID: 26141607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Connective tissue metabolism in scleroderma, including cytokines.
    Unemori EN; Amento EP
    Curr Opin Rheumatol; 1996 Nov; 8(6):580-4. PubMed ID: 9018463
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Connective tissue metabolism including cytokines in scleroderma.
    Postlethwaite AE
    Curr Opin Rheumatol; 1994 Nov; 6(6):616-20. PubMed ID: 7865383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathogenic role of CCL2/MCP-1 in scleroderma.
    Yamamoto T
    Front Biosci; 2008 Jan; 13():2686-95. PubMed ID: 17981743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of collagen type I, fibronectin and dermal fibroblast function and activity, in systemic sclerosis by the antioxidant epigallocatechin-3-gallate.
    Dooley A; Shi-Wen X; Aden N; Tranah T; Desai N; Denton CP; Abraham DJ; Bruckdorfer R
    Rheumatology (Oxford); 2010 Nov; 49(11):2024-36. PubMed ID: 20627968
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis.
    Liakouli V; Cipriani P; Di Benedetto P; Ruscitti P; Carubbi F; Berardicurti O; Panzera N; Giacomelli R
    Mod Rheumatol; 2018 Nov; 28(6):922-932. PubMed ID: 29351724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Constitutive thrombospondin-1 overexpression contributes to autocrine transforming growth factor-beta signaling in cultured scleroderma fibroblasts.
    Mimura Y; Ihn H; Jinnin M; Asano Y; Yamane K; Tamaki K
    Am J Pathol; 2005 May; 166(5):1451-63. PubMed ID: 15855645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mutant fibrillin 1 from tight skin mice increases extracellular matrix incorporation of microfibril-associated glycoprotein 2 and type I collagen.
    Lemaire R; Farina G; Kissin E; Shipley JM; Bona C; Korn JH; Lafyatis R
    Arthritis Rheum; 2004 Mar; 50(3):915-26. PubMed ID: 15022335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanisms of skin fibrosis in systemic sclerosis.
    Jinnin M
    J Dermatol; 2010 Jan; 37(1):11-25. PubMed ID: 20175837
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells.
    Gilbane AJ; Denton CP; Holmes AM
    Arthritis Res Ther; 2013; 15(3):215. PubMed ID: 23796020
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression and regulation of intracellular SMAD signaling in scleroderma skin fibroblasts.
    Mori Y; Chen SJ; Varga J
    Arthritis Rheum; 2003 Jul; 48(7):1964-78. PubMed ID: 12847691
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Matrix Stiffness: the Conductor of Organ Fibrosis.
    Santos A; Lagares D
    Curr Rheumatol Rep; 2018 Jan; 20(1):2. PubMed ID: 29349703
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insights into the molecular mechanism of chronic fibrosis: the role of connective tissue growth factor in scleroderma.
    Leask A; Denton CP; Abraham DJ
    J Invest Dermatol; 2004 Jan; 122(1):1-6. PubMed ID: 14962082
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disruption of transforming growth factor beta signaling and profibrotic responses in normal skin fibroblasts by peroxisome proliferator-activated receptor gamma.
    Ghosh AK; Bhattacharyya S; Lakos G; Chen SJ; Mori Y; Varga J
    Arthritis Rheum; 2004 Apr; 50(4):1305-18. PubMed ID: 15077315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of calcitriol on fibroblasts derived from skin of scleroderma patients.
    Boelsma E; Pavel S; Ponec M
    Dermatology; 1995; 191(3):226-33. PubMed ID: 8534941
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sirt1 regulates canonical TGF-β signalling to control fibroblast activation and tissue fibrosis.
    Zerr P; Palumbo-Zerr K; Huang J; Tomcik M; Sumova B; Distler O; Schett G; Distler JH
    Ann Rheum Dis; 2016 Jan; 75(1):226-33. PubMed ID: 25180292
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanical tension and integrin alpha 2 beta 1 regulate fibroblast functions.
    Eckes B; Zweers MC; Zhang ZG; Hallinger R; Mauch C; Aumailley M; Krieg T
    J Investig Dermatol Symp Proc; 2006 Sep; 11(1):66-72. PubMed ID: 17069012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of integrin alpha(v)beta3 contributes to the establishment of autocrine TGF-beta signaling in scleroderma fibroblasts.
    Asano Y; Ihn H; Yamane K; Jinnin M; Mimura Y; Tamaki K
    J Immunol; 2005 Dec; 175(11):7708-18. PubMed ID: 16301681
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.